2008

Levodopa/carbidopa treatment of children with Angelman Syndrome

Clinical Trial
Levodopa
Share

$72,855

ASF has previously supported work at understanding if levodopa might have a potential therapeutic role in AS. This grant provides partial support to a larger clinical trial study which is aimed at implementing a controlled trial of levodopa supplementation to a group of children with AS. Individuals enrolled in the study will have a battery of developmental tests and neurological assessments periodically during a 1 to 2 year treatment phase.